Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361907 · ClinicalTrials.gov registry record · Phase 2
Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes
A Phase 2 study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT00361907 is a Phase 2 study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 105 participants.
The verdict
NCT00361907, a Phase 2 study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of Pulsatile Intravenous Insulin therapy on circulating blood markers. These blood markers are selected due to their correlation to and possible pathogenetic roles in vascular compromise and inflammatory malfunction in diabetic patients.
Interventions
- PROCEDURE Effect of Pulsatile IV insulin on diabetic pt blood markers
- PROCEDURE Effect of Pulsatile IV Insulin on blood markers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2005-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00361907
The ClinicalTrials.gov registry entry for NCT00361907 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Effect of Pulsatile IV insulin on diabetic pt blood markers is the first listed.
NCT00361907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00361907 about?
NCT00361907 is a clinical study titled "Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes". The purpose of this study is to determine the effect of Pulsatile Intravenous Insulin therapy on circulating blood markers. These blood markers are selected due to their correlation to and possible pathogenetic roles in vascular compromise and inflammatory malfunction in diabetic patients.
What is the current status of trial NCT00361907?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2005-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00361907?
The interventions under investigation include: Effect of Pulsatile IV insulin on diabetic pt blood markers (PROCEDURE), Effect of Pulsatile IV Insulin on blood markers (PROCEDURE).
Who is sponsoring clinical trial NCT00361907?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.